AbbVie On A STEAP Learning Curve In ADCs

 
• By Andrew McConaghie
  
AbbVie building
AbbVie continues to manage Humira erosion despite rising biosimilar market share • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Therapy Areas